Ulrich M. Zanger

Statistics

Publications

165

Citations

18.6K

H-Index

Active since

1986

Affiliations

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology(Current)

University of Tübingen

Charité - Universitätsmedizin Berlin

Humboldt-Universität zu Berlin

Robert Bosch (Germany)

Ulrich M. Zanger is an author at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology specializing in pharmacology, medicine, and pharmacogenetics.

ORCID

Publications per year

1986–2021

165

Publications

165

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

Frank J. Gonzalez, Radek C. Skodat, Shioko Kimura et al. · Nature · 1988 · 718 citations

Life Sciences, Genetics, Molecular Genetics +12

The genetic determinants of the CYP3A5 polymorphism

Elisabeth Hustert, Michael Haberl, Oliver Burk et al. · Pharmacogenetics · 2001 · 670 citations

Medicine, Genetics, Molecular Genetics +13

Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.

Thomas Lang, Kathrin Klein, Joachim E. Fischer et al. · Pharmacogenetics · 2001 · 569 citations

Medicine, Genetics, Molecular Genetics +17

Sex Is A Major Determinant of Cyp3a4 Expression in Human Liver

Renzo Wolbold, Kathrin Klein, Oliver Burk et al. · Hepatology · 2003 · 510 citations · Full text

Medicine, Pharmacology, Toxicology +13

Breast Cancer Treatment Outcome With Adjuvant Tamoxifen Relative to Patient CYP2D6 and CYP2C19 Genotypes

Werner Schroth, Lydia Antoniadou, Péter Fritz et al. · Journal of Clinical Oncology · 2007 · 466 citations

Medicine, Oncology, Pharmacology +17

1–5 of 165